CSLLY:OTCMKTS
CSL ADR
$32.21
0.00%
(0.00) 1D
$32.21
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSLLY...
Open
$32.07
High
$32.84
Low
$32.07
Mkt. cap
88.84B
Avg. vol.
92.02K
Volume
46.00K
52-wk high
$36.28
52-wk low
$16.01
Beta
0.53
Shares outstanding
1.92B
No. of employees
29K
Open
$32.07
High
$32.84
Low
$32.07
Mkt. cap
88.84B
Avg. vol.
92.02K
Volume
46.00K
52-wk high
$36.28
52-wk low
$16.01
Beta
0.53
Shares outstanding
1.92B
No. of employees
29K
News stories
From web sources and news partners
The Motley Fool Australia
·
3 hours ago
CSL, Westpac, BHP shares: Buy, hold, or sell?
ad-hoc-news.de
·
16 hours ago
CSL stock trades at EUR 114.24 with AUD 88.5 billion market cap
ad-hoc-news.de
·
21 hours ago
CSL signs rare-disease deal and CSL stock costs EUR 114.58
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com